adv pharm part 2 week 2

profilerosario08
finalpresentationinCCPPPPadvpharm.ppt

Community Acquired Pneumonia

Case study

The condition that will be focused on is Community Acquired Pneumonia

The patient’s name is Joel who is sixty eight years old

The patient has no history of any other related issues

Joel has been a smoker for more than forty years

The patient reported the following symptoms

Cough

Fatigue

Sweating

Shortness of breath

Community Acquired Pneumonia is a condition that affects the respiratory system. The condition affects people of all ages as long as they are exposed to harmful bacteria and virus that cause the condition. Community Acquired Pneumonia is a condition that has caused many deaths in the world and that is proof that the condition is serious and dangerous.

*

Case study (continuation)

Vital signs

BP 152/90

HR 112/minute

Respiratory Rate 24/minute

Temp 102.6

Physical findings

Vomiting

Nausea

Chest Radiograph

The consolidation of the left lobe

Lab results

WBC 17,000/mm3

Neutrophils 70%

Lymphocytes 15%

Negative test for flu

The diagnosis of Joel revealed that he was suffering from CAP. The results that have been shared on the slide are proof that his health was not in a good condition. The vital signs revealed that the blood pressure was not normal. Vomiting and nausea were also signs and symptoms that revealed that Joel was not doing well as far as his health is concerned.

*

Description of the illness

Community Acquired Pneumonia is a respiratory illness that is caused by;

Fungi

Virus

Bacteria

The condition affects young and old

Pathogens differ based on the age of the patient

Some of the signs related to the illness are

Lower body temperature

Chest pain when breathing and coughing

Community Acquired Pneumonia is an illness that has three different causes namely; virus, fungi, and bacteria. It therefore means that the risks of contracting the illness are high. Despite the fact that the condition affects people of different ages, the elderly members of society are highly affected. The lack of strong immune is one of the reasons why the elderly are at a high risk. Also, it is important to note that when people get older, their body organs do not function as affective as those of younger persons.

*

Pathophysiology

Inhalation is the most common route of Community Acquired Pneumonia

The infection promotes the inflammatory of the alveoli

People who are 65 years and above are more exposed to the risk of acquiring CAP

Conditions such as bronchiectasis increase the vulnerability levels of the patient

The condition promotes the constriction of the airways

Typical bacteria and viral pathogens are some of the most common pathogens

The most common route of CAP is inhaling. The illness affects the respiratory system and that means that breathing in and out are highly affected. The vulnerability levels of patients is dictated by the age of patients as well as the presence of other condition. Presence of other conditions affects the immune of the patient and that exposes the patient to CAP.

*

Signs and symptoms

Fatigue

Sweating

Shaking chills

Diarrhea

Shortness of breath

Lower body temperature and Fever

Cough

Chest pain

Some of the signs and symptoms of the illness are as stated. It is no doubt that the symptoms affect the effectiveness of the body as well as daily engagements of the patient.

*

Medication management

Fluoroquinolones

Ciprofloxacin 750 mg (every 12 hours) 3 days

Levofloxacin 500 mg for 7 days

Fluoroquinolones should not be recommended for children

Tetracyclines

Doxycycline 200 mg (given twice in a duration of 12 hours)

Tetracycline 50 mg/kg in four different and equal doses

Tetracyclines are suitable for both children and elder patients

Fluoroquinolones and Tetracyclines are also on the list of the medicines that are used to treat Community Acquired Pneumonia. However, the two types of medications have restrictions when it comes to the ages of the patients. Children should not take Fluoroquinolones. When it comes to tetracyclines, there are no limitations. Young and elder patients are allowed to take the drugs.

*

barriers to practice

Side effects

The side effects of a drug can affect the intake of the drug

When the side effects are dire, the prescription should be changed

Some of the possible side effects are;

Intestinal infection

Nausea

Vomiting

Diarrhea

Barrier to medications is dictated by different factors. One of the factors is associated with the side effects of the medicines. In some cases and patients, there are side effects. The side effects might affect the healing process or even make the condition worse. It therefore means that they must be changed. In cases where the side effects are known before the administration of drugs, there are barriers to administration.

*

barriers to practice

The nature of the condition is complex

It is easy to misdiagnose the illness

If not detected on time, there are high chances of death

The drugs might have serious and life threatening side effects

Increased experience is needed for practitioners

There are different barriers to the practice. One of the barriers is associated with the complexity of the condition (Pliakos, Andreatos, Tansarli, Ziakas, & Mylonakis, 2019). When a condition is complex, the practitioners must have the skills and experience to deal with it.

*

Overcoming the barriers

Promote patient literacy

Increase practitioner education

Educate patients how to avoid the condition by;

Maintaining hygiene

Maintaining oral hygiene

Avoiding smoking

Seeking immediate medical help when there are symptoms

It is important to deal with the barriers once and for all with the main aim of promoting a healthy population. Patient education is paramount in this case because it will help patients to protect their health. One of the barriers is the complexity of the condition. It would therefore be important to make sure that practitioners have the skills and knowledge they need to become effective and of help to patients.

*

expected outcomes

Increased quality of life

The quality of life changes during illnesses

When a condition improves, the quality of life increases

It, therefore, means that administering medications will help to improve the quality of life

The medicines are supposed to make the condition of the patient better

Taking the pain away will help to improve the quality of life

One of the expected outcomes is increased quality of life. Helping the patient to live better through the condition will be improving the quality of his life. The pain will reduce and soon, the patient will get better (Uranga et al. 2017). It therefore means that the life of the patient will get back on track soon.

*

expected outcomes

Containment of the condition

Community Acquired Pneumonia is a condition that can affect the life of a patient

It is important to contain it

The medication will be helping to make sure that it does not advance to another stage

One of the expected outcome is to help the patient get through the condition

It is important to make sure that patients get through their condition smoothly. One of the outcomes that are expected is to ensure that the patient goes through the whole process without challenges (Metlay et al. 2019). Healthcare practitioners are not only expected to offer treatments but they are also supposed to offer support to patients to make sure that before healing, the misery is reduced.

*

follow up care

The patient will be monitored for the next fifteen days

The follow up will

The second follow up will be after a month

The patient will be asked to come for a test after week

Also, the patient will be called thrice a week to know how he is doing

In the case of anything, the patient will be advised to call the hospital

The health of a patient is paramount. Following patients after discharge is a norm in healthcare. The same will be promoted in this case. The following up will be make sure that the patient is getting better.

*

multiple choice questions

Which of the following is not a medication for Community Acquired Pneumonia?

Fluoroquinolones

Macrolide antibiotics

Tetracyclines

Hedex

Community Acquired Pneumonia affects people who are how many years old?

12 years old

2 years old

65 years old

All of the above

multiple choice questions

Which of the following is not one of the expected outcomes?

Increased quality of life

Containment of the condition

Healing

Increase pain

Which one of the following is not a side effects of CAP drugs?

Intestinal infection

Nausea

Vomiting

Increased appetite

multiple choice questions

Can Macrolide antibiotics help to treat CAP?

Yes

No

Maybe

There is no evidence

References

Tansarli, G. S., & Mylonakis, E. (2018). Systematic review and meta-analysis of the efficacy of short-course antibiotic treatments for community-acquired pneumonia in adults. Antimicrobial agents and chemotherapy, 62(9).

Pliakos, E. E., Andreatos, N., Tansarli, G. S., Ziakas, P. D., & Mylonakis, E. (2019). The Cost-Effectiveness of Corticosteroids for the Treatment of Community-Acquired Pneumonia. Chest, 155(4), 787-794.

Uranga, A., España, P. P., Bilbao, A., Quintana, J. M., Arriaga, I., Intxausti, M., ... & Capelastegui, A. (2016). Duration of antibiotic treatment in community-acquired pneumonia: a multicenter randomized clinical trial. JAMA internal medicine, 176(9), 1257-1265.

References

Metlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K., ... & Griffin, M. R. (2019). Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. American journal of respiratory and critical care medicine, 200(7), e45-e67.

Wu, W. F., Fang, Q., & He, G. J. (2018). Efficacy of corticosteroid treatment for severe community-acquired pneumonia: A meta-analysis. The American journal of emergency medicine, 36(2), 179-184.